Table 3.
Age- and sex-specific mean in-hospital days, physician visits and drugs for the treatment of chronic conditions
| |
|
Males |
Females |
Age/sex standard |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age group (years) | 65-69 | 70-74 | 75-79 | 80-84 | 85-90 | 65-69 | 70-74 | 75-79 | 80-84 | 85-90 | ||
|
Inhospital days |
KORA-Age |
2.8 |
2.5 |
3.1 |
3.3 |
5.4 |
3.7 |
2.7 |
3.7 |
4.0 |
5.1 |
3.4 |
| AOK SHI fund 2009* |
2.4 |
4.9 |
5.1 |
5.5 |
7.0 |
3.7 |
3.2 |
5.1 |
5.0 |
5.7 |
4.3 |
|
| Delta as a % |
18% |
−49% |
−40% |
−40% |
−23% |
1% |
−14% |
−27% |
−20% |
−11% |
−21% |
|
|
AOK SHI fund 2006 |
3.6 |
4.1 |
4.5 |
5.1 |
5.3 |
2.3 |
3.4 |
4.0 |
4.6 |
5.3 |
3.9 |
|
|
Delta 2006 as a % |
−22% |
−39% |
−31% |
−35% |
2% |
63% |
−21% |
−7% |
−14% |
−3% |
−13% |
|
|
Physician visits |
KORA-Age |
9.2 |
9.5 |
10.7 |
12.7 |
13.2 |
9.8 |
10.7 |
11.4 |
14.4 |
13.0 |
10.9 |
| AOK SHI fund 2009* |
29.0 |
36.3 |
38.7 |
39.8 |
43.0 |
33.0 |
36.2 |
39.2 |
37.4 |
40.5 |
35.9 |
|
| Delta as a % |
−68% |
−74% |
−72% |
−68% |
−69% |
−70% |
−70% |
−71% |
−62% |
−68% |
−70% |
|
|
AOK SHI fund 2006 |
28.2 |
33.3 |
36.0 |
37.1 |
38.4 |
30.1 |
32.3 |
33.8 |
36.2 |
38.2 |
33.1 |
|
|
Delta 2006 as a % |
−67% |
−71% |
−70% |
−66% |
−66% |
−68% |
−67% |
−66% |
−60% |
−66% |
−67% |
|
| Number of drugs for treatment of chronic conditions | KORA-Age |
1.9 |
2.2 |
2.8 |
2.9 |
2.9 |
1.9 |
2.2 |
2.6 |
3.0 |
3.1 |
2.4 |
| AOK SHI fund 2009* |
2.3 |
2.5 |
2.8 |
2.8 |
3.3 |
2.3 |
2.5 |
3.0 |
3.1 |
3.5 |
2.7 |
|
| Delta as a % |
−17% |
−9% |
0% |
4% |
−12% |
−16% |
−9% |
−12% |
−5% |
−10% |
−9% |
|
|
AOK SHI fund 2006 |
1.9 |
2.2 |
2.3 |
2.4 |
2.4 |
1.9 |
2.2 |
2.5 |
2.7 |
2.6 |
2.2 |
|
| Delta 2006 as a % | 2% | 2% | 21% | 24% | 18% | 3% | 2% | 6% | 12% | 21% | 8% | |
*Extrapolated from 2006 data.